YAN KANG

Partner·Beijing

YAN KANG

Partner·Beijing

YAN KANG

Partner·Beijing

PROFILE REPRESENTATIVE MATTERS AND CASES OTHER INFORMATION Further Reading

MR. KANG SPECIALIZES IN PRIVATE EQUITY AND CAPITAL MARKET.

Education

China Renmin University, School of Law, LL.B

Professional Qualification

Admitted to practice in the PRC

Professional Background

Before joining Fangda Partners, Mr. Kang was a partner of Commerce & Finance law Offices and Haiwen Partners.

PROFILE

REPRESENTATIVE MATTERS AND CASES

  • Private Equity

  • Capital Market

  • Represented KKR in its investments in Modern Dairy, the largest dairy farming company in China
  • Represented Morgan Stanley in its investments in China Flooring Holding Company Limited, a leading flooring brand in china
  • Represented KKR in its investments in Rundong Group, a leading luxury 4S dealership group in China
  • Represented CMC in its investments in Ourgame, a leading online games company in China
  • Represented CMC in its investments in IT companies
  • Represented Morgan Stanley in its investments in hospitals
  • Represented CDH in its investments in the agriculture sector
  • Represented KKR in its investments in real estate
  • Represented Morgan Stanley in its investment in Yongye International Inc, a NASDAQ-listed company
  • Represented Morgan Stanley in its investment in China XD Plastics Company Limited, a NYSE-listed company
  • Represented KKR in its investment in Qingdaohaier (600690), an A-share listed company
  • Represented KKR in its investment in Shengnong Development (002299), an A-share listed company
  • Represented the issuer in the IPO and listing on the Hong Kong Stock Exchange of RD Mobile (01365)
  • Represented the sponsors in the IPO and listing on the NASDAQ of iDreamSky Technology (DSKY)
  • Represented the issuer in the IPO and listing on the Hong Kong Stock Exchange of Logan PPT (03380)
  • Represented the sponsors in the IPO and listing on the Hong Kong Stock Exchange of CH MODERN D (03380)
  • Represented the issuer in the IPO and listing on the Hong Kong Stock Exchange of SIHUAN PHARM (00460)

OTHER INFORMATION